Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL3 | Q96JM7 | 5/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.34 |
| ▸ | TP53BP1 | Q12888 | 2/20 | 0.34 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.33 |
| ▸ | TRIM24 | O15164 | 2/20 | 0.33 |
| ▸ | TRIM33 | Q9UPN9 | 2/20 | 0.33 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.33 |
| ▸ | OPRL1 | P41146 | 2/20 | 0.33 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.33 |
| ▸ | DRD2 | P14416 | 1/20 | 0.33 |
| ▸ | MBTD1 | Q05BQ5 | 1/20 | 0.32 |
| ▸ | L3MBTL4 | Q8NA19 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL3665053 | 0.97 | L3MBTL3 (0.33) | L3MBTL3L3MBTL1TP53BP1KCNH2TRIM24 | |
| SCHEMBL6628090 | 0.90 | OPRM1 (0.43) | L3MBTL3L3MBTL1OPRM1OPRL1HRH3 | |
| SCHEMBL4213726 | 0.90 | MAPK1 (0.43) | L3MBTL3L3MBTL1TP53BP1TRIM24TRIM33 | |
| SCHEMBL10203442 | 0.89 | KDM4E (0.43) | ALDH1A1 | |
| SCHEMBL10203440 | 0.89 | KDM4E (0.43) | ALDH1A1 | |
| SCHEMBL13240324 | 0.89 | KDM4E (0.43) | ALDH1A1 | |
| SCHEMBL27917725 | 0.89 | KCNH2 (0.33) | L3MBTL3L3MBTL1TP53BP1KCNH2OPRM1 | |
| SCHEMBL551401 | 0.87 | OPRM1 (0.46) | OPRM1OPRL1HRH3ALDH1A1OPRK1 | |
| SCHEMBL7634170 | 0.87 | OPRM1 (0.46) | OPRM1OPRL1HRH3ALDH1A1OPRK1 | |
| SCHEMBL21047675 | 0.87 | OPRM1 (0.46) | OPRM1OPRL1HRH3ALDH1A1OPRK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 223 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119529292-A | Polyarylpiperidine anion exchange resin, anion exchange membrane, and preparation methods and application thereof | 重庆曼恩斯特新材料科技有限公司 | 2025-02-28 | — | — | CN | claimed |
| CN-106589355-B | Non-viral gene transfection carrier material of the one kind based on cationic helical polypeptide | 广州医科大学 | 2019-02-01 | — | — | CN | claimed |
| CN-106589355-A | Non-viral gene transfection vector material based on cationic helical peptide | 广州医科大学 | 2017-04-26 | — | — | CN | claimed |
| EP-4200297-B1 | IMIDAZO[1,2-A]PYRIDINE AND [1,2,4]TRIAZOLO[1,5-A]PYRIDINE DERIVATIVES AS TLR9 INHIBITORS FOR THE TREATMENT OF FIBROSIS | BRISTOL MYERS SQUIBB CO (US) | 2026-05-13 | — | — | EP | disclosed |
| US-12589092-B2 | Polycyclic compound acting as kinase inhibitor | HANGZHOU INNOGATE PHARMA CO., LTD. (CN) | 2026-03-31 | — | — | US | disclosed |
| US-12486267-B2 | Imidazo[1,2-A]pyridine and [1,2,4]triazolo[1,5-A]pyridine derivatives as TLR9 inhibitors for the treatment of fibrosis | BRISTOL-MYERS SQUIBB COMPANY (US) | 2025-12-02 | — | — | US | disclosed |
| WO-2025201453-A1 | MACROCYCLIC COMPOUNDS AS RAS INHIBITORS | BEIGENE (SUZHOU) CO., LTD. (CN) | 2025-10-02 | — | — | WO | disclosed |
| US-20250282755-A1 | SMALL MOLECULE STIMULATORS OF STEROID RECEPTOR COACTIVATOR-3 AND METHODS OF THEIR USE AS CARDIOPROTECTIVE AND/OR VASCULAR REGENERATIVE AGENTS | BAYLOR COLLEGE OF MEDICINE (US) | 2025-09-11 | — | — | US | disclosed |
| EP-4089092-B1 | POLYCYCLIC COMPOUND ACTING AS KINASE INHIBITOR | HANGZHOU INNOGATE PHARMA CO LTD (CN) | 2025-09-10 | — | — | EP | disclosed |
| US-12338229-B2 | Small molecule stimulators of steroid receptor coactivator-3 and methods of their use as cardioprotective and/or vascular regenerative agents | BAYLOR COLLEGE OF MEDICINE (US) | 2025-06-24 | — | — | US | disclosed |
| CN-120136844-A | Small molecule stimulators of steroid receptor coactivator-3 and methods of their use as cardioprotective and/or revascularizing agents | 贝勒医学院 | 2025-06-13 | — | — | CN | disclosed |
| WO-2004087700-A1 | BENZENESULPHONAMIDE DERIVATIVES, METHOD FOR PRODUCTION AND USE THEREOF FOR TREATMENT OF PAIN | LABORATOIRES FOURNIER S.A. (FR) | 2004-10-14 | — | — | WO | disclosed |
| US-4372961-A | REACTING A 3-AMINORIFAMYCIN S WITH A 4-PIPERIDONE, ANTIBIOTICS | BRUZZESE TIBERIO (IT) | 1983-02-08 | — | — | US | disclosed |
| US-4238607-A | ANTIBIOTICS, SEDATIVES, HYPOTENSIVE AGENTS, AND ANTIDEPRESSANTS | ENDO LABORATORIES INC. (US) | 1980-12-09 | — | — | US | disclosed |
| US-4183936-A | SEDATIVES, ANTIDEPRESSANTS, HYPOTENSIVE AGENTS, BACTERICIDES | ENDO LABORATORIES, INC. (US) | 1980-01-15 | — | — | US | disclosed |
| US-4174453-A | HYDROGENATION, ACIDFICATION | ENDO LABORATORIES, INC. (US) | 1979-11-13 | — | — | US | disclosed |
| US-4115577-A | SEDATIVES, ANTIDEPRESSANT ANTIHYPERTENSIVE, ANTIBACTERIAL | ENDO LABORATORIES, INC. (US) | 1978-09-19 | — | — | US | disclosed |
| US-4013652-A | SEDATIVES | ENDO LABORATORIES, INC. (US) | 1977-03-22 | — | — | US | disclosed |
| US-4005208-A | GASTRIC JUICE, ANTISECRETORY | SMITHKLINE CORPORATION (US) | 1977-01-25 | — | — | US | disclosed |
| US-3991199-A | ANALGESICS AND SEDATIVES | ENDO LABORATORIES, INC. (US) | 1976-11-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250282755-A1 | SMALL MOLECULE STIMULATORS OF STEROID RECEPTOR COACTIVATOR-3 AND METHODS OF THEIR USE AS CARDIOPROTECTIVE AND/OR VASCULAR REGENERATIVE AGENTS | NCOA3, FABP3, NCOA1 | L3MBTL3 3804/4885L3MBTL1 4452/4885TP53BP1 2366/4885 |
| US-12338229-B2 | Small molecule stimulators of steroid receptor coactivator-3 and methods of their use as cardioprotective and/or vascular regenerative agents | NCOA3, FABP3, NCOA1 | L3MBTL3 3804/4885L3MBTL1 4452/4885TP53BP1 2366/4885 |
| US-12589092-B2 | Polycyclic compound acting as kinase inhibitor | CDK1, CDK4, CDK2 | L3MBTL3 2123/4885L3MBTL1 1608/4885TP53BP1 1764/4885 |
| US-12486267-B2 | Imidazo[1,2-A]pyridine and [1,2,4]triazolo[1,5-A]pyridine derivatives as TLR9 inhibitors for the treatment of fibrosis | TLR9, TLR1, TLR7 | L3MBTL3 4707/4885L3MBTL1 3982/4885TP53BP1 1066/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.